NCT01108653

Brief Summary

In this study the investigators aim at comparing the effect on quality of life and the cost-effectiveness of a structuralised sick-leave program compared to usual care sick leave management in patients after an acute non ST myocardial infarction(NSTEMI).The investigators hypothesize that a structuralised sick-leave program after an acute NSTEMI is cost-effective without a negative effect on quality of life compared to usual care management in this patient group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 22, 2010

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

May 7, 2010

Status Verified

January 1, 2010

Enrollment Period

2.9 years

First QC Date

April 19, 2010

Last Update Submit

May 6, 2010

Conditions

Keywords

Cardiovascular diseasesHeart diseasesMyocardial infarctionRehabilitationHealth EconomyRandomized controlled trialsNon ST Elevation Myocardial Infarction (NSTEMI)Cost analysisSick-leaveQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Cost effectiveness

    In order to evaluate resource use (costs) all patients will be asked to fill in a questionnaire at baseline and after 6 and 12 months. Total costs and mean costs will be calculated in the two different follow-up modalities.

    one year

Secondary Outcomes (1)

  • Quality of Life measures are estimated at baseline and after 6 and 12 months using the standard Medical Outcomes Study Short form( SF-36)questionnaire and the disease-specific Utility-Based Quality of life-Heart questionnaire(UBQ-H).

    one year

Study Arms (2)

Group 1: Usual care sick-leave management

OTHER
Other: Usual care sick-leave management

Group 2: Structuralised sick-leave program

OTHER
Other: Structuralised sick-leave program

Interventions

Patients randomized to usual care. Follow up after discharge by general practitioner (GP) according to local practice.

Group 1: Usual care sick-leave management

Patients randomized to the structuralized program will get full time sick-leave for 2 weeks after discharge.Cardiologist will be responsible for individual adaption of each patient's sick-leave and follow-up.

Group 2: Structuralised sick-leave program

Eligibility Criteria

AgeUp to 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with acute NSTEMI who are revascularized.
  • years old or less
  • Self caring
  • Adequately literate in Norwegian
  • Have a regular work in at least 50% position.

You may not qualify if:

  • Patients not willing to participate
  • Professional drivers
  • Patients with alcohol or drug abuse
  • Severe complications after the myocardial infarction such as malignant arrythmias, heart failure and major bleedings.
  • Patients with recent CABG ( coronary artery bypass graft operation) within the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, Trondheimsveien 235, 0514, Norway

RECRUITING

MeSH Terms

Conditions

Myocardial InfarctionCardiovascular DiseasesHeart DiseasesNon-ST Elevated Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Stefan Agewall, Professor

    Oslo University Hospital. Department of Cardiology. Trondheimsveien 235, 0514 Oslo, Norway

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stefan Agewall, Professor, MD.PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 19, 2010

First Posted

April 22, 2010

Study Start

January 1, 2010

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

May 7, 2010

Record last verified: 2010-01

Locations